Anthrax mounts a nuclear attack on glucocorticoid signaling

Area of Science:

• * Microbiology and Immunology
• * Molecular Biology
• * Toxicology

Background:

• * Anthrax is a severe infectious disease characterized by significant inflammation and systemic shock.
• * The glucocorticoid receptor plays a vital role in regulating the body's inflammatory response.
• * Anthrax lethal toxin is a primary virulence factor contributing to disease severity.

Purpose of the Study:

• * To investigate the effect of anthrax lethal toxin on the transcriptional activity of the glucocorticoid receptor.
• * To elucidate the molecular mechanism by which anthrax lethal toxin interferes with glucocorticoid receptor function.
• * To explore potential therapeutic targets for anthrax by understanding glucocorticoid receptor inactivation.

Main Methods:

• * Assays to measure transcriptional activity of the glucocorticoid receptor.
• * Western blotting or similar techniques to assess the p38 mitogen-activated protein kinase pathway.
• * Cell-based or in vitro experiments exposing cells to anthrax lethal toxin.

Main Results:

• * Anthrax lethal toxin was found to repress the transcriptional activity of the glucocorticoid receptor.
• * Evidence suggests that lethal toxin inhibits the p38 mitogen-activated protein kinase pathway.
• * Glucocorticoid receptor inactivation was linked to the mechanisms of anthrax toxicity.

Conclusions:

• * Glucocorticoid receptor inactivation is a significant factor contributing to anthrax pathogenesis.
• * Targeting the p38 mitogen-activated protein kinase pathway may offer a novel strategy for treating anthrax.
• * Understanding the interaction between anthrax toxins and host defense pathways is crucial for developing effective countermeasures.